SCA Pharmaceuticals Recalls Glycopyrrolate Injection Due to Labeling Error
SCA Pharmaceuticals is recalling 972 syringes of Glycopyrrolate injection distributed in Louisiana because a printing error made the expiration date appear incorrect.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text identifies the issue as a minor labeling error (printing overlap) without reporting any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
SCA Pharmaceuticals is voluntarily recalling 972 syringes of Glycopyrrolate injection, 0.2 mg per mL (1 mg/5 mL), 5 mL Fill in 10 mL Syringe. The affected product was distributed in Louisiana. The recall involves two specific lots: 20141218@41 with a use-by date of 3/18/2015, and 20141226@24 with a use-by date of 3/26/2015.
The recall was initiated due to a labeling defect. A printing error caused the characters "y" and "3" to overlap, making the actual "Use By 3/2015" date appear to read "Use By 8/2015". This discrepancy could lead to the use of expired medication.
Consumers and healthcare providers who have this product should stop using it and contact SCA Pharmaceuticals at 877-550-5059 for further instructions. The product is prescription-only.
The recalled product
- Product
- Glycopyrrolate injection, 0.2 mg per mL (1 mg/5 mL), 5 mL Fill in 10 mL Syringe, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205, 877-550-5059
- Manufacturer
- SCA Pharmaceuticals
- Category
- Drug — Injection
- Hazard
- Affected units
- 972
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 20141218@41
- Use by 3/18/2015
- 20141226@24
- Use by 3/26/2015
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · SCA Pharmaceuticals
See all →- HighSCA Pharmaceuticals Fentanyl-Bupivacaine Injectable Recall Due to Manufacturing Deviations
FDA (Drugs) · 2023-08-02
- ModerateFDA recalls Oxytocin product for low potency nationwide
FDA (Drugs) · 2023-05-03
- ModerateFentanyl Injection Syringes Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2023-03-08
- ModerateNorepinephrine Injection Recalled Nationwide for Manufacturing Quality Deviations
FDA (Drugs) · 2022-05-11
- ModerateDrug recall: fentanyl and bupivacaine injectable solution manufacturing deviations
FDA (Drugs) · 2022-05-11
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereSCA Pharmaceuticals Recalls Glycopyrrolate Syringes Due to Sterility Concerns
FDA (Drugs) · 2021-01-13
- LowSCA Pharmaceuticals Recalls Labetalol HCl Injection Due to Labeling Errors
FDA (Drugs) · 2018-03-14
- LowAccord Recalls Glycopyrrolate Injection Due to Labeling Mix-up
FDA (Drugs) · 2021-02-17
- ModeratePharmakon Recalls Glycopyrrolate Syringes Due to Stability Data Concerns
FDA (Drugs) · 2016-02-03
- HighGlycopyrrolate Syringes Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-27
- HighPrescription Glycopyrrolate Injection Recalled Due to Manufacturing Process Deviations
FDA (Drugs) · 2023-03-08